Inpharma Weekly

, Volume 1545, Issue 1, pp 20–20 | Cite as

Dolasetron: Health Canada advises of contraindications

Correspondence
  • 3 Downloads

Keywords

Myocardial Infarction Serotonin Receptor Antagonist Mesylate Cancer Chemotherapy 

Copyright information

© Adis International Ltd 2006

Personalised recommendations